A groundbreaking shift in Canadian drug policy has occurred, as the regulators permit the legalization of psilocybin fungi for therapeutic purposes. Until now, these substances were severely restricted, but a increasing body of research suggests they may offer benefits for mental health conditions like anxiety. The new policy represents a substanti